KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other Non-Current Assets: 2018-2024

Historic Other Non-Current Assets for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $2.9 million.

  • Adaptive Biotechnologies' Other Non-Current Assets fell 10.00% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 10.00%. This contributed to the annual value of $2.9 million for FY2024, which is 19.24% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Other Non-Current Assets stood at $2.9 million for FY2024, which was down 19.24% from $3.6 million recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Other Non-Current Assets registered a high of $3.6 million during FY2023, and its lowest value of $2.1 million during FY2020.
  • Over the past 3 years, Adaptive Biotechnologies' median Other Non-Current Assets value was $2.9 million (recorded in 2024), while the average stood at $3.0 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 49.63% in 2023, then decreased by 19.24% in 2024.
  • Yearly analysis of 5 years shows Adaptive Biotechnologies' Other Non-Current Assets stood at $2.1 million in 2020, then remained steady at $2.1 million in 2021, then rose by 12.25% to $2.4 million in 2022, then skyrocketed by 49.63% to $3.6 million in 2023, then fell by 19.24% to $2.9 million in 2024.